| Carbidopa and Levodopa | Impax | ||
| 23.75/95mg, 36.25/145mg, 48.75/195mg; Capsule, extended release |
Less Than $1000 mn
|
||
|
Less Than 5
|
More Than 5
|
||
|
More Than 5
|
Less Than 5
|
||
| None | None | ||
| Indicated for Parikinson's disease. | |||
|
Yes
| |||
| Rytary | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 |
|---|---|---|---|---|---|---|---|---|---|
| ******* (****) | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ****** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ***** ****** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******* (****) | *** \ *** | ***** **, **** | ******* | **** | ****** **** ******** |
| ****** | ** \ ** | *** *, **** | ******* | ********* ******** | ***** ***-**** *********** |
| ***** ****** | ** \ ** | **** **, **** | ******* | ********* ******** | ***** ***-**** *********** |
| Carbidopa and Levodopa | Impax | ||
| 61.25mg/ 245mg Capsule, extended release |
Less Than $1000 mn
|
||
|
Less Than 5
|
More Than 5
|
||
|
More Than 5
|
Less Than 5
|
||
| None | None | ||
| Indicated for Parkinsons disease | |||
|
Yes
| |||
| Rytary | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 |
|---|---|---|---|---|---|---|---|---|---|
| ******* (****) | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ****** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ***** ****** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******* (****) | *** \ *** | ***** **, **** | ******* | **** | ****** **** ******** |
| ****** | ** \ ** | *** *, **** | ******* | ********* ******** | ***** ***-**** *********** |
| ***** ****** | ** \ ** | **** **, **** | ******* | ********* ******** | ***** ***-**** *********** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|